CCP
MRNA icon

Clough Capital Partners’s Moderna MRNA Stock Holding History

Clough Capital Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-49,040
Closed -$11.5M – 137
2021
Q2 		$11.5M Buy
49,040
+13,118
+37% +$2.34M 0.63% 61
2021
Q1 		$4.7M Sell
35,922
-19,140
-35% -$2.77M 0.21% 81
2020
Q4 		$5.75M Sell
55,062
-222,240
-80% -$22.5M 0.41% 68
2020
Q3 		$19.6M Buy
277,302
+147,472
+114% +$10.3M 1.41% 24
2020
Q2 		$8.34M Buy
+129,830
New +$7.11M 0.82% 42

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Clough Capital Partners's MRNA Position: Q3 2021 in Review

Clough Capital Partners sold out of Moderna (MRNA) in Q3 2021, closing a stake of 49,040 shares — an estimated $11.5M sold.

Clough Capital Partners first reported a position in MRNA in Q2 2020 and held it in 5 quarters. The position peaked at $19.6M in Q3 2020. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Clough Capital Partners reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • Clough Capital Partners sold 49,040 Moderna shares in Q3 2021, an estimated $11.5M.
  • Clough Capital Partners first reported a position in Moderna in Q2 2020 and held it in 5 quarters.
  • Clough Capital Partners's Moderna position peaked at $19.6M in Q3 2020.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Clough Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.